Order Entry
United States
ContactUsLinkComponent
Human Recombinant SLAMF7 (from HEK293)
Human Recombinant SLAMF7 (from HEK293)
Supplier:  ACROBIOSYSTEMS
Certificates
Human Recombinant SLAMF7 (from HEK293)
Supplier:  ACROBIOSYSTEMS

Specifications

  • Protein/Peptide Type:
    Recombinant
  • Source:
    HEK293 cells
  • Species:
    Human
  • Storage Conditions:
    –20 °C
  • Endotoxin Content:
    Less than 1.0 EU per μg by the LAL method.
  • Biological Activity:
    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.; Measured by its binding ability in a functional ELISA. Immobilized Humanized Anti-Human CS1 MAb at 1 μg/mL (100 μL/well) can bind Biotinylated Human SLAMF7, Avitag,His Tag (Cat. No. SL7-H82E0) with a linear range of 0.6-5 ng/mL (Routinely tested).; 2e5 of Anti-SLAMF7 CAR-293 cells were stained with 100 μL of 0.1 μg/mL of Biotinylated Human SLAMF7, Avitag, His Tag (Cat. No. SL7-H82E0) and negative control protein respectively, washed and then followed by PE-SA and analyzed with FACS (QC tested).
  • Gene ID:
    Q9NQ25-1
  • Carrier-Free:
    Y
  • Protease-free:
    Y
  • Animal-Free:
    Y
  • Protein Synonyms:
    FOAP-12|CRACC|19A|CS1|CD319|SLAMF7
  • Protein/Peptide Name:
    SLAMF7
  • Purity:
    >95%
  • Molecular Weight:
    25.6 kDa
  • Endotoxin Level:
    Low
  • Formulation:
    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.
  • Nuclease-free:
    Y
  • Shipping Temperature:
    Powder,RT

Specifications

Frequently Bought Together